Re-evaluation of the VIDAS® cytomegalovirus (CMV) IgG avidity assay: Determination of new cut-off values based on the study of kinetics of CMV-IgG maturation

Journal of Clinical Virology

Volumn 56, Issue 2, 2013, Pages 118-123

  Vauloup Fellous, Christelle ^a   Berth, Mario ^b   Heskia, Fabienne ^c   Dugua, Jean Marc ^c   Grangeot Keros, Liliane ^a  

^a INSERM   (France)

^b Algemeen Medisch Laboratorium   (Belgium)

^c BIOMÉRIEUX   (France)

Author keywords

CMV IgG avidity; Cytomegalovirus; Primary infection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; ASSAY; AUTOMATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; KINETICS; MALE; PRIMARY INFECTION; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PREGNANCY;

EID: 84872416962     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.10.017     Document Type: Article

References (17)

1. Dobbins J.G., Stewart J.A., Demmler G.J. Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Summ 1992, 41(2):35-39.
2. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007, 17(5):355-363.
3. Yinon Y., Farine D., Yudin M.H. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can 2010, 32(4):348-354.
4. Stagno S., Pass R.F., Dworsky M.E., Henderson R.E., Moore E.G., Walton P.D., et al. Congenital cytomegalovirus infection. The relative importance of primary and recurrent maternal infection. New Engl J Med 1982, 306:945-949.
5. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New Engl J Med 1992, 326(10):663-667.
6. Boppana S.B., Fowler K.B., Britt W.J., Stagno S., Pass R.F. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999, 104(1 Pt 1):55-60.
7. Dussaix E., Chantot S., Harzic M., Grangeot-Keros L. CMV-IgG avidity and CMV-IgM concentration in both immunocompromised and immunocompetent patients. Pathol Biol 1996, 44(5):405-410.
8. Grangeot-Keros L., Mayaux M.J., Lebon P., Freymuth F., Eugene G., Stricker R., et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997, 175:944-946.
9. Lazzarotto T., Spezzacatena P., Varani S., Gabrielli L., Pradelli P., Guerra B., et al. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol 1999, 6(1):127-129.
10. Ross S.A., Novak Z., Pati S., Boppana S.B. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drugs Targets 2011, 11:466-474.
11. Blackburn N.K., Besselaar T.G., Schoub B.D., O'Connell K.F. Differentiation of cytomegalovirus infection from reactivation using denaturation test for measuring antibody avidity. J Med Virol 1991, 33(1):6-9.
12. Baccard-Longere M., Freymuth F., Cointe D., Seigneurin J.M., Grangeot-Keros L. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol 2001, 8(2):429-431.
13. Bodéus M., Beulné D., Goubau P. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2001, 20:248-252.
14. de Souza S., Bonon S.H.A., Costa S.C.B., Rossi C.L. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection. Rev Inst Med Trop Sao Paulo 2003, 45(6):323-326.
15. Curdt I., Praast G., Sickinger E., Schultess J., Herold I., Braun H.B., et al. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the validity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG avidity assays. J Clin Microbiol 2009, 47(3):603-613.
16. Revello M.G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 2010, 48(4):255-259.
17. Lagrou K., Bodeus M., Van Ranst M., Goubau P. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J Clin Microbiol 2009, 47(6):1695-1699.